202 related articles for article (PubMed ID: 4179401)
1. Antibody responses in serum and nasal secretions of children immunized with inactivated and attenuated measles-virus vaccines.
Bellanti JA; Sanga RL; Klutinis B; Brandt B; Artenstein MS
N Engl J Med; 1969 Mar; 280(12):628-33. PubMed ID: 4179401
[No Abstract] [Full Text] [Related]
2. Immunoglobulin responses in serum and nasal secretions after natural adenovirus infections.
Bellanti JA; Artenstein MS; Brandt BL; Klutinis BS; Buescher EL
J Immunol; 1969 Nov; 103(5):891-8. PubMed ID: 4187116
[No Abstract] [Full Text] [Related]
3. Antibody response in serum and nasopharynx after naturally acquired and vaccine-induced infection with rubella virus.
Ogra PL; Kerr-Grant D; Umana G; Dzierba J; Weintraub D
N Engl J Med; 1971 Dec; 285(24):1333-9. PubMed ID: 4107718
[No Abstract] [Full Text] [Related]
4. Measles antibodies in nasal secretions and sera of children with measles.
Polna I; Aleksandrowicz J; Krawczyński K; Krotochwil-Skrzypek M; Rozskowska K
Acta Virol; 1977 Jul; 21(4):331-7. PubMed ID: 20768
[TBL] [Abstract][Full Text] [Related]
5. [Immunoglobulin classes of antibodies produced by inoculation of attenuated live measles vaccine].
Sekiguchi H; Numazaki Y; Ikeda M; Yano N
Iryo; 1970 Jan; 24(1):21-3. PubMed ID: 4191377
[No Abstract] [Full Text] [Related]
6. Localization of measles antibody and inhibitor activity in fractions of human sera at different stages of the disease, and sera of animals immunized with measles virus. I. Dynamics of increase in measles antibody activity and its localization in children sera after natural infection.
Polna I; Aleksandrowicz J; Roszkowska K
Acta Microbiol Pol A; 1973; 5(3):131-8. PubMed ID: 4203632
[No Abstract] [Full Text] [Related]
7. [Activities of immune globulins at the time of measles vaccine inoculation and measles infection, with special reference to sensitivity and resistance of the antibody to 2-mercaptoethanol].
Arai M; Nakamura M
Nihon Shonika Gakkai Zasshi; 1969 Dec; 73(12):2032-7. PubMed ID: 4191839
[No Abstract] [Full Text] [Related]
8. Aerosol immunization of humans with inactivated parainfluenza type 2 vaccine.
Wigley FM; Fruchtman MH; Waldman RH
N Engl J Med; 1970 Dec; 283(23):1250-3. PubMed ID: 4320010
[No Abstract] [Full Text] [Related]
9. [Measurement of the in vitro immune response of live attenuated measles virus vaccine and antibody levels in 0 to 10-year-old children].
Unalan H; Ustaçelebi S
Mikrobiyol Bul; 1985 Oct; 19(4):218-28. PubMed ID: 3831724
[TBL] [Abstract][Full Text] [Related]
10. [Study of clinical reactions and the fluctuation of antibody levels after measles vaccination. (1) Clinical reactions and serum antibody values after vaccination with raw vaccine only].
Kubota K
Nihon Shonika Gakkai Zasshi; 1967 Dec; 71(12):1478-83. PubMed ID: 4175590
[No Abstract] [Full Text] [Related]
11. Development of extremely attenuated live measles virus vaccine (CAM-EX).
Ueda S; Takahashi M; Kurimura T; Minekawa Y; Suzuki N
Biken J; 1972 Sep; 15(3):173-7. PubMed ID: 4643692
[No Abstract] [Full Text] [Related]
12. Studies on further attenuated live measles vaccine. VIII. Estimated duration of immunity after vaccination without natural infection.
Ueda S; Okuno Y; Sakamoto Y; Sangkawibha N; Tuchinda P
Biken J; 1974 Mar; 17(1):11-20. PubMed ID: 4854462
[No Abstract] [Full Text] [Related]
13. [Characterization of the antibodies inhibiting complement fixation in the sera of cattle immunized with an anti-aphthous vaccine].
Hessami M; Roumiantzeff M; Salvatori J; Caillere F
Bull Off Int Epizoot; 1969; 71(3-4):443-62. PubMed ID: 4101093
[No Abstract] [Full Text] [Related]
14. [Studies on immunity to measles. II. Prophylactic and serological studies on the use of live and attenuated measles-virus vaccine].
Egami T
Kumamoto Igakkai Zasshi; 1966 May; 40(5):539-62. PubMed ID: 4164172
[No Abstract] [Full Text] [Related]
15. Live, attenuated mumps-virus vaccine.
Hilleman MR; Buynak EB; Weibel RE; Stokes J
N Engl J Med; 1968 Feb; 278(5):227-32. PubMed ID: 4169706
[No Abstract] [Full Text] [Related]
16. Measles vaccination in Iceland: three-year follow-up of antibody titres in adults and children.
Black FL; Gudnadóttir M
Bull World Health Organ; 1966; 35(6):955-7. PubMed ID: 4165239
[No Abstract] [Full Text] [Related]
17. [Evaluation of the vaccination of a misture of inactivated and live measles vaccines. 1. Clinicoserological observation for a period of 4 years].
Tanaka H
Nihon Shonika Gakkai Zasshi; 1972 Mar; 76(3):162-9. PubMed ID: 5065657
[No Abstract] [Full Text] [Related]
18. Anamnestic secretory antibody response in respiratory secretions of intranasally immunized mice.
Gerbrandy JL; van Dura EA
J Immunol; 1972 Nov; 109(5):1146-8. PubMed ID: 5079093
[No Abstract] [Full Text] [Related]
19. The response of ponies to Myxovirus influenzae A-equi 2. II. Immunoglobulin classes of antibody to the virus in serum and nasal secretions.
Rouse BT; Ditchfield WJ
Can J Comp Med; 1970 Jan; 34(1):7-12. PubMed ID: 4192439
[TBL] [Abstract][Full Text] [Related]
20. Studies on further attenuated live measles vaccine. 3. Selection of less reactive variants of CAM measles vaccine virus.
Takaku K; Sasada T; Konobe T; Onishi K; Ueda S
Biken J; 1970 Sep; 13(3):163-8. PubMed ID: 5530510
[No Abstract] [Full Text] [Related]
[Next] [New Search]
